Trial Profile
Phase 1 study of AB171 evaluating pharmacokinetics and clinical tolerability.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Nov 2017
Price :
$35
*
At a glance
- Drugs AB-171 (Primary)
- Indications Chronic heart failure; Peripheral arterial disorders
- Focus Adverse reactions; Pharmacokinetics
- 22 Nov 2017 New trial record